A patient with newly diagnosed non-small cell lung cancer (NSCLC) presents with fatigue, shortness of breath, and elevated liver enzymes indicating potential metastatic spread. Which nursing intervention should be prioritized to address the patient's immediate needs?

A) Administer supplemental oxygen to address shortness of breath

B) Initiate nutritional support to address fatigue and decreased hemoglobin

C) Arrange for a consultation with a hepatologist to manage liver dysfunction

D) Educate the patient about potential chemotherapy side effects

A patient with newly diagnosed non-small cell lung cancer (NSCLC) and suspected liver metastasis is experiencing fatigue and shortness of breath. Which nursing intervention should the nurse prioritize to address the patient's respiratory symptoms and overall well-being?

B) Administer supplemental oxygen as prescribed to alleviate shortness of breath.

A) Educate the patient about smoking cessation to prevent further lung damage.

B) Administer supplemental oxygen as prescribed to alleviate shortness of breath.

C) Schedule frequent rest periods to manage fatigue effectively.

D) Encourage an increased fluid intake to help with liver function.

A patient with a known pleural effusion and hemoptysis is experiencing increased shortness of breath and decreased oxygen saturation. Which nursing intervention should be prioritized to address the patient's current respiratory status?

B) Prepare the patient for thoracentesis to remove pleural fluid.

A) Administer a bronchodilator to open the airways.

B) Prepare the patient for thoracentesis to remove pleural fluid.

C) Increase the oxygen flow rate to improve oxygen saturation.

D) Encourage the patient to take deep breaths to expand the lungs.

A patient with known lung cancer presents with increased shortness of breath, persistent cough with hemoptysis, and an oxygen saturation of 90% on room air. A chest X-ray reveals a pleural effusion on the right side. What is the priority nursing intervention to address the patient's respiratory distress?

A) Administer supplemental oxygen to maintain adequate saturation

B) Prepare the patient for immediate thoracentesis to relieve the pleural effusion

C) Monitor vital signs every hour to assess for further changes in respiratory status

D) Administer a bronchodilator to open the airways and improve breathing

A patient has undergone a thoracentesis, revealing malignant cells in the pleural fluid and negative bacterial cultures. The interdisciplinary team is considering treatment adjustments. As a nurse, what is the most appropriate action to take in this situation?

B) Facilitate a family meeting to discuss the patient's treatment goals and preferences.

A) Prepare the patient for immediate chemotherapy initiation.

B) Facilitate a family meeting to discuss the patient's treatment goals and preferences.

C) Arrange for a blood transfusion to address the anemia immediately.

D) Increase the oxygen flow rate to improve the patient's respiratory status.

A patient with metastatic cancer has just undergone a thoracentesis, resulting in improved respiratory status. The patient, however, continues to suffer from fatigue and generalized weakness due to anemia, with a hemoglobin level of 10.8 g/dL. What is the nurse's priority action in managing this patient's anemia?

B) Monitor the patient's hemoglobin levels while providing nutritional support.

A) Administer a blood transfusion immediately to increase hemoglobin levels.

B) Monitor the patient's hemoglobin levels while providing nutritional support.

C) Increase the oxygen flow rate to help alleviate fatigue symptoms.

D) Prepare the patient for a repeat thoracentesis to further improve breathing.

A patient with metastatic cancer has shown increased shortness of breath, a return of mild inspiratory crackles, and a decrease in oxygen saturation despite oxygen therapy. The patient's BNP levels are elevated, and there is a noted reaccumulation of pleural fluid upon chest X-ray. Which of the following interventions should the nurse anticipate as a priority to address the patient's current respiratory distress?

B) Prepare the patient for a repeat thoracentesis

A) Administer an increased dose of opioids for pain management

B) Prepare the patient for a repeat thoracentesis

C) Initiate diuretic therapy as prescribed

D) Increase the patient's oxygen flow rate beyond 4 liters per minute

A patient with a history of metastatic cancer presents with increased shortness of breath, mild inspiratory crackles, and a decrease in oxygen saturation. A chest X-ray shows reaccumulation of pleural fluid and possible cardiomegaly. B-type natriuretic peptide (BNP) levels are elevated. Which nursing intervention is the priority to address the patient's respiratory distress?

C) Administer prescribed diuretics to reduce fluid overload

A) Increase the oxygen flow rate to improve saturation

B) Prepare the patient for repeat thoracentesis

C) Administer prescribed diuretics to reduce fluid overload

D) Elevate the head of the bed to facilitate breathing

The nursing team is planning care for a patient with moderate reaccumulation of pleural fluid and signs of heart failure. Which nursing intervention should be prioritized to address the patient's respiratory distress and fluid overload?

B) Prepare the patient for a repeat thoracentesis to remove pleural fluid.

A) Administer oxygen therapy to improve oxygen saturation.

B) Prepare the patient for a repeat thoracentesis to remove pleural fluid.

C) Initiate intravenous diuretics as prescribed to manage fluid overload.

D) Restrict fluid intake to prevent further fluid accumulation.

A patient with a history of malignancy presents with shortness of breath and diagnostic findings suggestive of heart failure with reduced ejection fraction and pleural effusion. The BNP is elevated, indicating volume overload. Which nursing intervention should be prioritized to address the patient's respiratory distress while considering the overall management of the cardiac condition?

B) Preparing the patient for a repeat thoracentesis to reduce pleural fluid

A) Administering supplemental oxygen to maintain oxygen saturation above 92%

B) Preparing the patient for a repeat thoracentesis to reduce pleural fluid

C) Initiating diuretic therapy as prescribed to manage fluid overload

D) Encouraging fluid intake to prevent dehydration and maintain renal function

cancer - Nursing Case Study

Pathophysiology

• Primary mechanism: Genetic mutations - Cancer primarily arises from genetic mutations that disrupt normal cell cycle regulation. These mutations can lead to uncontrolled cell proliferation, enabling the formation of tumors. Key genes involved include oncogenes (promote growth) and tumor suppressor genes (inhibit growth).

• Secondary mechanism: Angiogenesis - To sustain rapid growth, cancer cells stimulate the formation of new blood vessels (angiogenesis), ensuring an adequate supply of oxygen and nutrients. This process not only supports tumor expansion but also facilitates metastasis, where cancer cells spread to other parts of the body.

• Key complication: Metastasis - This is the process by which cancer cells invade surrounding tissues and spread through the bloodstream or lymphatic system to distant organs, complicating treatment and significantly worsening prognosis.

Patient Profile

Demographics:

52-year-old male, construction worker

History:

• Key past medical history: Hypertension, type 2 diabetes

• Current medications: Metformin, lisinopril, atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent cough and unexplained weight loss

• Key symptoms: Fatigue, shortness of breath, night sweats

• Vital signs: Blood pressure 145/92 mmHg, heart rate 102 bpm, respiratory rate 22 breaths/min, temperature 100.1°F

Section 1

As the patient undergoes further evaluation, new diagnostic results reveal notable findings. A recent CT scan of the chest indicates a suspicious mass in the right lung, measuring approximately 3.5 cm in diameter, with irregular borders suggestive of malignancy. Additionally, small nodules are noted in the liver, raising the concern for potential metastatic spread. A subsequent biopsy of the lung mass confirms the presence of non-small cell lung cancer (NSCLC), a common type of lung cancer often associated with smoking and environmental exposures, factors relevant to the patient's occupational background as a construction worker.

Laboratory tests reveal an elevated white blood cell count of 14,000/mm³, indicating a possible inflammatory response or infection secondary to the tumor. The patient's hemoglobin level is slightly decreased at 11.5 g/dL, which may contribute to his reported fatigue and shortness of breath. Liver function tests show mildly elevated liver enzymes, supporting the suspicion of metastatic involvement. These results necessitate a multidisciplinary approach to care, involving oncology, pulmonology, and potentially, hepatology for comprehensive evaluation and management.

Given these findings, the healthcare team must engage in clinical reasoning to prioritize interventions. The primary focus should be on addressing the patient's respiratory symptoms and assessing the extent of the metastatic disease. Initiating discussions about possible treatment options, such as chemotherapy, targeted therapy, or immunotherapy, is crucial, considering the patient's overall health, cancer stage, and personal preferences. The team must also consider supportive measures to manage symptoms such as cough, fatigue, and potential liver dysfunction, aiming to improve the patient's quality of life and prepare him for the next steps in his cancer journey.

Section 2

As the interdisciplinary team continues to monitor the patient, a change in status becomes apparent during a routine assessment. The patient reports increased shortness of breath and a persistent cough, now accompanied by hemoptysis. Physical examination reveals diminished breath sounds in the right lung and crackles in the left base, indicating possible fluid accumulation. Vital signs show a slight increase in respiratory rate to 24 breaths per minute and a heart rate of 110 beats per minute, suggesting a compensatory response to potential hypoxia or anemia. Oxygen saturation has dropped to 90% on room air, prompting the need for supplemental oxygen to maintain adequate levels.

In response to these developments, a follow-up chest X-ray is performed, revealing a pleural effusion on the right side, likely secondary to the tumor's presence and possible infection or inflammation. This finding necessitates a thoracentesis to relieve respiratory distress and obtain fluid for cytological examination, which may provide further insight into the metastatic process. Concurrently, the patient's hemoglobin level continues to decline, now at 10.8 g/dL, warranting an evaluation for potential blood transfusion to address anemia.

These complications highlight the complexity of the patient's condition, requiring careful coordination among the healthcare team to manage respiratory symptoms and ensure adequate oxygenation while preparing for possible systemic treatment options. The findings reinforce the importance of ongoing monitoring and individualized care planning, as the team navigates the challenges of balancing aggressive cancer treatment with symptom management and overall quality of life considerations.

Section 3

The team proceeds with the thoracentesis, successfully aspirating 800 mL of straw-colored fluid from the right pleural space, which provides immediate relief in the patient's respiratory distress. The fluid is sent for cytological analysis and cultures to determine any infectious or malignant causes. Following the procedure, the patient's oxygen saturation improves to 94% with supplemental oxygen at 2 liters per minute via nasal cannula, and the respiratory rate decreases to 20 breaths per minute, indicating a positive response to the intervention. The patient's heart rate stabilizes at 98 beats per minute, suggesting improved hemodynamic status. However, the patient continues to report fatigue and generalized weakness, symptoms likely exacerbated by the ongoing anemia.

The cytology results return, revealing malignant cells consistent with metastatic spread from the primary tumor, which underscores the aggressive nature of the disease. Cultures from the pleural fluid are negative for bacterial growth, ruling out a concurrent infectious process. With the hemoglobin level persistently low at 10.8 g/dL, the team deliberates on the appropriateness of a blood transfusion, weighing the potential benefits of improved oxygen delivery against the risks of transfusion-related complications. A decision is made to monitor the hemoglobin trends closely while enhancing nutritional support and considering erythropoiesis-stimulating agents to address the anemia without immediate transfusion.

This development leads to a critical discussion among the interdisciplinary team about adjusting the treatment plan. The oncologist suggests a potential shift in the chemotherapy regimen to address the metastatic progression, while the palliative care team emphasizes the importance of maintaining the patient's quality of life. The team collectively decides to convene a family meeting to discuss the current status, potential treatment modifications, and align the care goals with the patient's wishes. This ensures that the patient remains at the center of care decisions, fostering an approach that respects both the clinical complexities and the holistic needs of the patient and family.

Section 4

As the team reconvenes to assess the patient's current condition, a notable change in the patient's status is observed. Over the following days, the patient begins to experience increased shortness of breath, despite the previously successful thoracentesis and stable oxygenation. The respiratory rate has risen again to 28 breaths per minute, and there is a return of mild inspiratory crackles upon auscultation of the lungs. The patient's oxygen saturation has decreased to 90% on 2 liters of oxygen via nasal cannula, prompting an increase to 4 liters to maintain adequate levels. The clinical team suspects a possible reaccumulation of pleural effusion or further metastatic involvement of the lung tissue.

In addition to respiratory changes, the patient reports new onset chest discomfort and a persistent dry cough, which raises concerns for potential cardiovascular complications. A follow-up chest X-ray reveals a moderate reaccumulation of pleural fluid on the right side and possible cardiomegaly. The patient's blood pressure is noted to be slightly elevated at 142/88 mmHg, and a new lab result shows an increase in B-type natriuretic peptide (BNP) levels, suggesting possible cardiac strain or congestive heart failure as contributing factors to the patient's worsening symptoms.

These developments necessitate an urgent multidisciplinary discussion to address the evolving clinical picture. The potential need for repeat thoracentesis is evaluated while also considering the initiation of diuretics to manage any underlying heart failure. The oncology team remains focused on controlling the metastatic spread and stabilizing the patient's condition, while palliative care continues to advocate for symptom relief and quality of life. This prompts another family meeting to reassess treatment goals, ensuring they align with the patient's evolving condition and preferences, and paving the way for a revised, comprehensive care plan.

Section 5

As the team reconvenes to discuss the patient's evolving clinical status, attention is drawn to the new diagnostic results that have emerged following additional investigations. A repeat chest X-ray confirms the moderate reaccumulation of pleural fluid on the right side, which correlates with the patient's increased shortness of breath and decreased oxygen saturation levels. Echocardiography is performed to further investigate the cardiomegaly noted in the previous imaging, revealing mild left ventricular hypertrophy and a reduced ejection fraction of 45%, indicative of systolic dysfunction. This new finding suggests that the patient is experiencing a degree of heart failure, likely exacerbated by the fluid overload from the pleural effusion and possibly metastatic cardiac involvement.

Additionally, laboratory tests provide further insights into the patient's condition. The BNP levels have risen to 550 pg/mL, reinforcing the suspicion of heart failure. A comprehensive metabolic panel reveals a mild hyponatremia with a sodium level of 132 mEq/L and a slight increase in creatinine to 1.4 mg/dL, hinting at potential renal involvement or effects from the cardiac strain. The patient's electrolyte imbalance and renal function will require careful monitoring, especially with the consideration of diuretics to manage the fluid overload. The team deliberates on the next steps, weighing the benefits and risks of a repeat thoracentesis to alleviate the respiratory distress versus the initiation of diuretics to address both pleural effusion and cardiac concerns.

As these diagnostic results are evaluated, the clinical team is tasked with integrating this new information into the patient's care plan. The oncology team remains vigilant regarding the progression of the malignancy, while cardiology and nephrology are consulted to provide expertise on managing the heart failure and fluid balance. This interdisciplinary approach emphasizes the need for coordinated care to ensure that the interventions align with the patient's overall treatment goals and quality of life considerations. The situation presents an opportunity for clinical reasoning as the team must decide on a course of action that addresses both the oncological and cardiovascular complexities of the case, setting the stage for the next phase of the patient's journey.